"Vi erbjuder läkemedelsprövningar, hälso- och intygsundersökningar samt tjänster till privatkunder. Kliniska läkemedelsstudier bidrar till att läkemedel med hög kvalitet kan utvecklas. Alla forskningsstudier och vaccinstudier är godkända av Läkemedelsverket och Etikprövningsnämnd."

During the past decade, Ladulaas Kliniska Studier conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ladulaas Kliniska Studier" #1 sponsor was "Pfizer" with 4 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Adial Pharmaceuticals" with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ladulaas Kliniska Studier" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ladulaas Kliniska Studier" are "Pneumococcal Disease" (2 trials), "Psoriasis" (2 trials), "Alcohol Use Disorder" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "COPD" (1 trials). Many other conditions were trialed in "Ladulaas Kliniska Studier" in a lesser frequency.

Most popular intervention types in "Ladulaas Kliniska Studier" are "Drug" (8 trials), "Other" (3 trials), "Biological" (2 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "13vPnC" (2 trials), "20vPnC" (2 trials), "BMS-986165" (2 trials) and "PPSV23" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ladulaas Kliniska Studier" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ladulaas Kliniska Studier". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Ladulaas Kliniska Studier, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ladulaas Kliniska Studier, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".